1-3 of 3
C. Revta
Close
Sort by
Journal Articles

Prediction of VOD Using Biomarkers of Endothelial Injury.

Corey Cutler, MD, MPH, J. Aldridge, H. T. Kim, S. Ayanian, G. Bradwin, C. Revta, G. Murga, V. Ho, E. Alyea, J. Koreth, P. Armand, P. G. Richardson, R. J. Soiffer, J. Ritz, J. H. Antin
Journal: Blood
Blood (2008) 112 (11): 3267.
https://doi.org/10.1182/blood.V112.11.3267.3267
Published: 2008
Journal Articles

Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (sVOD) and Multi-Organ Failure (MOF) Post SCT: Final Results of a Multi-Center, Randomized, Dose-Finding Trial.

Paul Richardson, MD, R.J. Soiffer, MD, J.H. Antin, MD, Z. Jin, PhD, J. Kurtzberg, MD, P.L. Martin, MD, G. Steinbach, MD, K.F. Murray, MD, G.B. Vogelsang, MD, A. Chen, MD, A. Krishnan, MD, N.A. Kernan, MD, D. Avigan, MD, T.R. Spitzer, MD, D. Warren, C. Revta, L.J. Wei, PhD, M. Iacobelli, MD, G.B. McDonald, MD, E.C. Guinan, MD
Journal: Blood
Blood (2006) 108 (11): 43.
https://doi.org/10.1182/blood.V108.11.43.43
Published: 2006
Journal Articles

Defibrotide (DF) for the Treatment of Veno-Occlusive Disease (VOD) and Multi-System Organ Failure (MOF) Post SCT: Analysis of Response and Survival According to Degree and Type of MOF.

Paul G. Richardson, MD, R. J. Soiffer, MD, J. H. Antin, MD, Z. Jin, PhD, J. Kurtzberg, MD, P. L. Martin, MD, D. Hockenbery, MD, K. F. Murray, MD, G. B. Vogelsang, MD, A. Chen, MD, A. Krishnan, MD, N. A. Kernan, MD, D. Avigan, MD, T. R. Spitzer, MD, D. Warren, P. Momtaz, C. Revta, L. J. Wei, PhD, M. Iacobelli, MD, G. B. McDonald, MD, E. C. Guinan, MD
Journal: Blood
Blood (2005) 106 (11): 399.
https://doi.org/10.1182/blood.V106.11.399.399
Published: 2005